US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CG Oncology Inc.

25.55

-0.7300-2.78%

Post-market: 25.550.0020+0.01%17:01 EDT

Volume:987.48K

Turnover:25.34M

Market Cap:1.95B

PE:-16.89

High:26.46

Open:26.45

Low:25.43

Close:26.28

Loading ...

Overview Company News Filings

Analysts’ Opinions Are Mixed on These NA Stocks: Reddit Inc Class A (RDDT) and CG Oncology, Inc. (CGON)

Biotech Alert: Searches spiking for these stocks today

CG Oncology, Inc. (CGON) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award

CG Oncology Is Maintained at Outperform by RBC Capital

CG Oncology, Inc. (CGON) Surges 25.0%: Is This an Indication of Further Gains?

Buy Rating for CG Oncology, Inc. Driven by Cretostimogene’s Potential in Bladder Cancer Treatment Amid BCG Shortage

RBC Raises Price Target on CG Oncology to $68 From $66, Keeps Outperform, Speculative Risk

MT Newswires Live

Why CG Oncology, Inc. (CGON) Surged on Monday

Small U.S. Stocks Move Upward; CG Oncology Top Leaders

BUZZ-U.S. STOCKS ON THE MOVE-Marriott, Wells Fargo, Insulet

CG Oncology's Bladder Cancer Drug Impresses Investors - Here's Why

CG Oncology Reports Durable Responses for Cretostimogene in Bladder Cancer Treatment; Shares Rise

MT Newswires Live

Dow Jumps Over 150 Points; Domino's Pizza Posts Upbeat Earnings

BUZZ-CG Oncology jumps after late-stage bladder cancer therapy data

CG Oncology Shares Jump 36.7% After Co Announces Late-Stage Cancer Study Data

THOMSON REUTERS

CG Oncology Shares Rise 40% Premarket After Co Announces Late-Stage Cancer Study Data

THOMSON REUTERS

CG Oncology Announces Promising Phase 3 Trial Results

CG Oncology Price Target Maintained With a $75.00/Share by HC Wainwright & Co.

Buy Rating for CG Oncology, Inc. Driven by Promising Therapeutic Developments and Strong Safety Profile of Creto

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CGON/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CGON","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGON\",,,,,undefined,":{"symbol":"CGON","market":"US","secType":"STK","nameCN":"CG Oncology Inc.","latestPrice":25.55,"timestamp":1750449600000,"preClose":26.28,"halted":0,"volume":987475,"hourTrading":{"tag":"盘后","latestPrice":25.55,"preClose":25.548,"latestTime":"17:01 EDT","volume":213998,"amount":5467648.2072,"timestamp":1750453260446},"delay":0,"floatShares":61126461,"shares":76225308,"eps":-1.512766,"marketStatus":"Market Closed","change":-0.73,"latestTime":"06-20 16:00:00 EDT","open":26.45,"high":26.46,"low":25.43,"amount":25344395.1035,"amplitude":0.039193,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.512766,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750665600000},"marketStatusCode":7,"adr":0,"listingDate":1706158800000,"exchange":"NASDAQ","adjPreClose":26.28,"preHourTrading":{"tag":"盘前","latestPrice":26.3,"preClose":26.28,"latestTime":"09:27 EDT","volume":880,"amount":23167.70104,"timestamp":1750426060083},"postHourTrading":{"tag":"盘后","latestPrice":25.55,"preClose":25.548,"latestTime":"17:01 EDT","volume":213998,"amount":5467648.2072,"timestamp":1750453260446},"volumeRatio":1.12153057934611,"optionData":{"bulkOrders":[{"symbol":"CGON","call":true,"expireDate":1750392000000,"strike":"25.0","timestamp":1750437161888,"price":1.01,"volume":3000,"amount":303000,"type":"-"},{"symbol":"CGON","call":true,"expireDate":1752811200000,"strike":"25.0","timestamp":1750437161888,"price":2.06,"volume":3000,"amount":618000,"type":"-"}]},"impliedVol":0.6456,"impliedVolPercentile":0.424},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGON\",,,,,undefined,":{"symbol":"CGON","floatShares":61126461,"roa":"-12.85%","roe":"-16.57%","lyrEps":-1.408697,"volumeRatio":1.12153057934611,"shares":76225308,"dividePrice":0,"high":26.46,"amplitude":0.039193,"preClose":26.28,"low":25.43,"week52Low":14.8,"pbRate":"2.76","psRate":"2941.93","week52High":40.47,"institutionHeld":0,"latestPrice":25.55,"eps":-1.512766,"divideRate":0,"volume":987475,"delay":0,"ttmEps":-1.512766,"open":26.45,"prevYearClose":28.68,"prevWeekClose":25.86,"prevMonthClose":25.62,"prevQuarterClose":24.49,"fiveDayClose":26.5,"twentyDayClose":26.22,"sixtyDayClose":27.54},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CGON\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532005818","title":"Analysts’ Opinions Are Mixed on These NA Stocks: Reddit Inc Class A (RDDT) and CG Oncology, Inc. (CGON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2532005818","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532005818?lang=en_us&edition=fundamental","pubTime":"2025-05-02 17:10","pubTimestamp":1746177016,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the NA sector with new ratings on Reddit Inc Class A (RDDT – Research Report) and CG Oncology, Inc. (CGON –...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-na-stocks-reddit-inc-class-a-rddt-and-cg-oncology-inc-cgon?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-na-stocks-reddit-inc-class-a-rddt-and-cg-oncology-inc-cgon?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B64PRP62.GBP","BK4077","BK4139","LU2360107168.USD","BK4141","LU1861215975.USD","LU1861220033.SGD","NA","CGON","IE00B3QW5Z07.USD","BK4547","BK4135","IE00BGHQF748.EUR","CG","LU2290526834.HKD","RDDT"],"gpt_icon":0},{"id":"2532000582","title":"Biotech Alert: Searches spiking for these stocks today","url":"https://stock-news.laohu8.com/highlight/detail?id=2532000582","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532000582?lang=en_us&edition=fundamental","pubTime":"2025-05-02 00:15","pubTimestamp":1746116123,"startTime":"0","endTime":"0","summary":"These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include:. Discover companies with rock-solid fundamentals in  TipRanks' Smart Value Newsletter.Receive undervalued stocks, resilient to market uncertainty,  delivered straight to your inbox.Tevogen Bio Holdings , 332% surge in interest. Pipeline and key clinical candidates for these companies:. Galmed is a clinical stage biopharmaceutical company focused on the development of Aramchol for liver and fibro-inflammatory diseases. The company has focused almost exclusively on developing Aramchol for the treatment of noncirrhotic nonalcoholic steatohepatitis, or NASH, and are currently developing Aramchol for Primary Sclerosing Cholangitis, or PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of liver disease.CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biotech-alert-searches-spiking-stocks-161523387.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-alert-searches-spiking-stocks-161523387.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MKKGY","BK4539","TVGNW","TVGN","IE00B4R5TH58.HKD","SNTI","BCDA","CMMB","GLMD","LU0320765489.SGD","BK4007","BK4585","CGON","BK4578","BK4588","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0211331839.USD","SWTX","NVS","IE0009355771.USD","LU0070302665.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","BCDAW","BK4139","IE00BJJMRZ35.SGD","RGLS","BK4532","LU0208291251.USD"],"gpt_icon":0},{"id":"2532000562","title":"CG Oncology, Inc. (CGON) May Report Negative Earnings: Know the Trend Ahead of Q1 Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2532000562","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532000562?lang=en_us&edition=fundamental","pubTime":"2025-05-01 22:01","pubTimestamp":1746108086,"startTime":"0","endTime":"0","summary":"CG Oncology, Inc.  is expected to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, the stock may move lower.While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.This company is expected to post quarterly loss of $0.36 per share in its upcoming report, which represents no change from the year-ago quarter.Please note that a negative Earnings ESP reading is not indicative of an earni","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cg-oncology-inc-cgon-may-140126686.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["STOK","CGON","CG"],"gpt_icon":0},{"id":"2532074030","title":"SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award","url":"https://stock-news.laohu8.com/highlight/detail?id=2532074030","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532074030?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:00","pubTimestamp":1746100800,"startTime":"0","endTime":"0","summary":"- Award recipients Honored at the American Urological Association's 2025 Annual Meeting -. - Fellowship designed to support the development of outstanding clinical cancer research investigators to improve the understanding and treatment of NMIBC -. Saum Ghodoussipour, M.D., Rutgers Cancer Institute of New Jersey: Dynamic intra-tumor heterogeneity in non-muscle invasive bladder cancer. “It is exciting to see the next generation of urologists bringing passion and commitment to improving bladder cancer care and patient outcomes,” said Sia Daneshmand, MD, Director of Urologic Oncology at USC/Norris Comprehensive Cancer Center and Chair of the Bladder Cancer Committee of the SUO-CTC. “We look forward to Drs. Ghodoussipour and Goodstein’s presentations at next year’s AUA.”About The Society of Urologic Oncology Clinical Trials Consortium SUO-CTC is a clinical research investigator network of over 600 m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/suo-ctc-cg-oncology-announce-120000764.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CGON","BK4139","IE00B64PRP62.GBP","IE00BGHQF748.EUR","CG","IE00B3QW5Z07.USD","BK4135"],"gpt_icon":0},{"id":"2531276485","title":"CG Oncology Is Maintained at Outperform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2531276485","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531276485?lang=en_us&edition=fundamental","pubTime":"2025-04-30 01:25","pubTimestamp":1745947500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 29, 2025 13:25 ET (17:25 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CG","CGON"],"gpt_icon":0},{"id":"2531566287","title":"CG Oncology, Inc. (CGON) Surges 25.0%: Is This an Indication of Further Gains?","url":"https://stock-news.laohu8.com/highlight/detail?id=2531566287","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531566287?lang=en_us&edition=fundamental","pubTime":"2025-04-29 21:10","pubTimestamp":1745932200,"startTime":"0","endTime":"0","summary":"CG Oncology, Inc.  shares ended the last trading session 25% higher at $27.97. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 15.3% loss over the past four weeks.This company is expected to post quarterly loss of $0.36 per share in its upcoming report, which represents no change from the year-ago quarter. Revenues are expected to be $0.6 million, up 13.2% from the year-ago quarter.While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.CG Oncology, Inc. is part of the Zacks Medical - Biomedical and Genetics industry. uniQure , another stock in the same industry, closed the last trading session 1.5% lower at $13.97. QURE has returned 13.7% in the past month.Today, you can download 7 Best Stocks for the Next 30 Days","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cg-oncology-inc-cgon-surges-131000493.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CG","IE00B64PRP62.GBP","BK4135","QURE","CGON","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4139"],"gpt_icon":0},{"id":"2531733861","title":"Buy Rating for CG Oncology, Inc. Driven by Cretostimogene’s Potential in Bladder Cancer Treatment Amid BCG Shortage","url":"https://stock-news.laohu8.com/highlight/detail?id=2531733861","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531733861?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:15","pubTimestamp":1745928946,"startTime":"0","endTime":"0","summary":"Analyst Alec Stranahan of Bank of America Securities maintained a Buy rating on CG Oncology, Inc. (CGON – Research Report), with a price target of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-cg-oncology-inc-driven-by-cretostimogenes-potential-in-bladder-cancer-treatment-amid-bcg-shortage?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-cg-oncology-inc-driven-by-cretostimogenes-potential-in-bladder-cancer-treatment-amid-bcg-shortage?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCG","CG","CGON"],"gpt_icon":0},{"id":"2531252783","title":"RBC Raises Price Target on CG Oncology to $68 From $66, Keeps Outperform, Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2531252783","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531252783?lang=en_us&edition=fundamental","pubTime":"2025-04-29 18:50","pubTimestamp":1745923836,"startTime":"0","endTime":"0","summary":"CG Oncology (CGON) has an average rating of buy and mean price target of $62.63, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CG","CGON"],"gpt_icon":0},{"id":"2531226924","title":"Why CG Oncology, Inc. (CGON) Surged on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2531226924","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531226924?lang=en_us&edition=fundamental","pubTime":"2025-04-29 14:02","pubTimestamp":1745906565,"startTime":"0","endTime":"0","summary":"The stock market kicked off the trading week on a mixed note, with two major indices ending in the green, as investors continued to digest more corporate earnings results.Among the bellwether indices, only the Nasdaq ended in the red, dropping 0.10 percent. In contrast, the Dow Jones grew by 0.28 percent and the S&P 500 inched up by 0.06 percent.Meanwhile, 10 companies mirrored a broader market optimism, as investors snapped up shares ahead of their first-quarter earnings performance in the next few days.CG Oncology, Inc. grew its share prices for a fifth straight day on Monday, surging 25.03 percent to end at $27.97 apiece as investors cheered the promising results of its bladder cancer treatment that could rival Johnson & Johnson’s.Following a two-year study, CG Oncology, Inc.  said that cretostimogene grenadenorepvec—its investigational monotherapy for high-risk non-muscle invasive bladder cancer  unresponsive to BCG treatment— reported a robust 42.3 percent response rate and 97.3 p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-cg-oncology-inc-cgon-060245872.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QLD","USAW.SI","USJW.SI","IE00B64PRP62.GBP","MNQmain","IE00BGHQF748.EUR","CG","QID","NQmain","TQQQ","BK4139","PSQ","TSYW.SI",".IXIC","BK4135","NVIW.SI","CGON","SQQQ","IE00B3QW5Z07.USD"],"gpt_icon":1},{"id":"2531263545","title":"Small U.S. Stocks Move Upward; CG Oncology Top Leaders","url":"https://stock-news.laohu8.com/highlight/detail?id=2531263545","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531263545?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:20","pubTimestamp":1745871600,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies added Monday, as the Russell 2000 Index increased 0.4%, and the S&P Small Cap 600 Index was up 0.3%.Among companies with a market value of $1 billion to $6.7 billion, CG Oncology Inc. was the best performer during the session, surging 25%, followed by ADMA Biologics Inc., which surged 12%. Foot Locker Inc. shares surged 10%, Biohaven Ltd. jumped 9.6%, and shares of Celldex Therapeutics Inc. jumped 9.1%.LZ Technology Holdings Ltd. Cl B was the biggest laggard, dropping 14%, followed by shares of InMode Ltd., which dropped 12%. Shares of Exodus Movement Inc. dropped 7.3%, Coincheck Group N.V. shares plunged 5.8%, and Goosehead Insurance Inc. Cl A tumbled 5.0%.Major U.S. stock indexes ended Monday mixed as the Nasdaq Composite Index declined 0.1%. Meanwhile, the S&P 500 Index increased 0.1%, and the Dow Jones Industrial Average added 0.3%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4139","BK4135","CGON","CG","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2530231194","title":"BUZZ-U.S. STOCKS ON THE MOVE-Marriott, Wells Fargo, Insulet","url":"https://stock-news.laohu8.com/highlight/detail?id=2530231194","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530231194?lang=en_us&edition=fundamental","pubTime":"2025-04-28 23:51","pubTimestamp":1745855481,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Marriott, Wells Fargo, InsuletEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: htt","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL4N3R61IT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNVD.UK","SPRBX","NVD2.UK","SAG","CNC","RVTY","RBOT","NVDD","BHVN","NVDU","TSYW.SI","NVDX","IE00B7SZLL34.SGD","INTJ","DPZ","3NVD.UK","NVD","SPCB","TLX.AU","GLMD","AZUL","EAF","AMPY","CGON","MTD","NEM","PODD","PLUG","SABR","VLRS","LU2063271972.USD","NVDS.UK","SPRB","MAR","NVDS","2NVD.UK","SWTX","ADMA","NVDY","OPRA","NVIW.SI","WOLF","WY","NVD3.UK"],"gpt_icon":1},{"id":"2531912232","title":"CG Oncology's Bladder Cancer Drug Impresses Investors - Here's Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2531912232","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531912232?lang=en_us&edition=fundamental","pubTime":"2025-04-28 23:14","pubTimestamp":1745853277,"startTime":"0","endTime":"0","summary":"CG Oncology, Inc.  announced on Saturday that cretostimogene grenadenorepvec monotherapy data were presented at the 2025 American Urological Association Annual Meeting.The Phase 3 BOND-003 Cohort C study is in patients with high-risk non-muscle invasive bladder cancer  unresponsive to Bacillus Calmette Guerin  treatment with carcinoma in situ  with or without Ta or T1 disease.The study reported 75.5% complete response  at any time, with 34 confirmed CRs at 24 months and nine patients pending their 24-month assessment as of the March 14, 2025, cutoff date.Also Read: ImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug. The 12—and 24-month CR rates are 50.7% and 42.3%, respectively, by K-M estimation.The median duration of response  is 28 months and ongoing. Notably, 97.3% of patients were free from progression to muscle-invasive disease at 24 months.Additionally, Cohort P, in patients with BCG-unresponsive Ta/T1 disease without CIS, showed an estimated 90.5% high-grade r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cg-oncologys-bladder-cancer-drug-151437058.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B64PRP62.GBP","BK4139","BK4135","IE00BGHQF748.EUR","ISBC","CR","BK4211","CG","BK4161","CGON","BCG","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2530523554","title":"CG Oncology Reports Durable Responses for Cretostimogene in Bladder Cancer Treatment; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2530523554","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530523554?lang=en_us&edition=fundamental","pubTime":"2025-04-28 23:05","pubTimestamp":1745852719,"startTime":"0","endTime":"0","summary":"CG Oncology  on Monday reported durable long-term outcomes from its phase 3 Bond-003 trial evaluating cretostimogene grenadenorepvec in patients with high-risk non-muscle invasive bladder cancer, or NMIBC, unresponsive to Bacillus Calmette Guerin.In Cohort C, 75.5% of patients achieved a complete response at any point during the study. At 24 months, 42.3% remained in complete response by Kaplan-Meier estimate, with 97.3% free from progression to muscle-invasive disease and 91.6% of initial responders remaining cystectomy-free.Early results from Cohort P, in patients with BCG-unresponsive Ta/T1 disease without carcinoma in situ, showed a 90.5% high-grade recurrence-free survival rate at both three and nine months. Treatment was well-tolerated with no grade 3 or higher treatment-related adverse events reported.The company is continuing to evaluate the therapy for potential regulatory submission.Shares of CG Oncology rose 34% in recent trading activity.Price: 30.06, Change: +7.69, Percent","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B64PRP62.GBP","CG","CGON","BK4135","BK4139","IE00B3QW5Z07.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2530289100","title":"Dow Jumps Over 150 Points; Domino's Pizza Posts Upbeat Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2530289100","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530289100?lang=en_us&edition=fundamental","pubTime":"2025-04-28 21:56","pubTimestamp":1745848584,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/04/45039697/dow-jumps-over-150-points-dominos-pizza-posts-upbeat-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PAPL","CGON","PCOM","TARA","DPZ","SPRB","SPRBX","NAAS","GLMD"],"gpt_icon":0},{"id":"2530289829","title":"BUZZ-CG Oncology jumps after late-stage bladder cancer therapy data","url":"https://stock-news.laohu8.com/highlight/detail?id=2530289829","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530289829?lang=en_us&edition=fundamental","pubTime":"2025-04-28 21:46","pubTimestamp":1745847971,"startTime":"0","endTime":"0","summary":"BUZZ-CG Oncology jumps after late-stage bladder cancer therapy data** Shares of cancer drug developer CG Oncology CGON.O rise 34% to $30** On late Saturday, CGON said its bladder cancer therapy, cretostimogene grenadenorepvec, showed 42.3% of patients maintained complete response at 24 months for high-risk bladder cancer patients who failed previous treatments, in an ongoing late-stage study** 97.3% of treated patients remained free from progression to more serious muscle-invasive bladder cancer at 24 months, co said** Early data from another patient group, Cohort P, showed 90.5% of patients remained free from high-grade recurrence at both 3 and 9 months** As of last close, stock down 22% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL4N3R61AO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","BK4139"],"gpt_icon":0},{"id":"2530928569","title":"CG Oncology Shares Jump 36.7% After Co Announces Late-Stage Cancer Study Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2530928569","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530928569?lang=en_us&edition=fundamental","pubTime":"2025-04-28 21:32","pubTimestamp":1745847164,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL4N3R61A2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGON","BK4139"],"gpt_icon":0},{"id":"2530887012","title":"CG Oncology Shares Rise 40% Premarket After Co Announces Late-Stage Cancer Study Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2530887012","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530887012?lang=en_us&edition=fundamental","pubTime":"2025-04-28 21:16","pubTimestamp":1745846192,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL4N3R617P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CGON"],"gpt_icon":0},{"id":"2530453403","title":"CG Oncology Announces Promising Phase 3 Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2530453403","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530453403?lang=en_us&edition=fundamental","pubTime":"2025-04-28 19:58","pubTimestamp":1745841533,"startTime":"0","endTime":"0","summary":"An announcement from CG Oncology, Inc. ( ($CGON) ) is now available. On April 26, 2025, CG Oncology announced promising results from its Phase 3 BO...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cg-oncology-announces-promising-phase-3-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cg-oncology-announces-promising-phase-3-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGON","BK4139","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4135","CG"],"gpt_icon":0},{"id":"2530405870","title":"CG Oncology Price Target Maintained With a $75.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2530405870","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530405870?lang=en_us&edition=fundamental","pubTime":"2025-04-28 19:57","pubTimestamp":1745841420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 28, 2025 07:57 ET (11:57 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CG","CGON"],"gpt_icon":0},{"id":"2530473434","title":"Buy Rating for CG Oncology, Inc. Driven by Promising Therapeutic Developments and Strong Safety Profile of Creto","url":"https://stock-news.laohu8.com/highlight/detail?id=2530473434","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530473434?lang=en_us&edition=fundamental","pubTime":"2025-04-28 18:16","pubTimestamp":1745835393,"startTime":"0","endTime":"0","summary":"Analyst Andres Y. Maldonado from H.C. Wainwright maintained a Buy rating on CG Oncology, Inc. (CGON – Research Report) and keeping the price target...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-cg-oncology-inc-driven-by-promising-therapeutic-developments-and-strong-safety-profile-of-creto?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-cg-oncology-inc-driven-by-promising-therapeutic-developments-and-strong-safety-profile-of-creto?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CG","CGON"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":94,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CGON\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"CGON","fiscalQuarterEnding":"2025/03","expectedEps":-0.39,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2025-03-28","symbol":"CGON","fiscalQuarterEnding":"2024/12","expectedEps":-0.41,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743134400000,"reportTimeType":"pre","actualEps":-0.48},{"market":"US","date":"2024-11-12","symbol":"CGON","fiscalQuarterEnding":"2024/09","expectedEps":-0.42,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CGON\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CGON\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1,"buy":0.8,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":10,"updateTime":1746244800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CGON\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CGON","date":"2025-06-20","current":-18.977435,"percent":0.903614,"low":-77.942097,"twenty":-49.032283,"median":-37.168124,"eighty":-26.449487,"high":-13.496527,"avg":-38.172694,"sd":14.718632,"marketCap":2003201094},"quantilePoints":[{"date":"2024-01-26","current":-62.124194,"twenty":-62.124194,"median":-62.124194,"eighty":-62.124194,"marketCap":2539823423},{"date":"2024-02-02","current":-61.712969,"twenty":-61.712969,"median":-60.379514,"eighty":-59.355029,"marketCap":2523011292},{"date":"2024-02-09","current":-63.452965,"twenty":-62.124194,"median":-60.590915,"eighty":-59.355029,"marketCap":2594147579},{"date":"2024-02-16","current":-77.177799,"twenty":-70.608092,"median":-61.918582,"eighty":-60.168112,"marketCap":3155259972},{"date":"2024-02-23","current":-75.080046,"twenty":-72.448911,"median":-64.672589,"eighty":-60.20714,"marketCap":3069497532},{"date":"2024-03-01","current":-72.705845,"twenty":-73.870179,"median":-70.608092,"eighty":-60.516111,"marketCap":2972433066},{"date":"2024-03-08","current":-64.818944,"twenty":-72.891228,"median":-69.827533,"eighty":-60.799064,"marketCap":2649992888},{"date":"2024-03-15","current":-60.493345,"twenty":-72.302556,"median":-67.469593,"eighty":-60.20714,"marketCap":2473149409},{"date":"2024-03-22","current":-66.867912,"twenty":-72.162706,"median":-65.355579,"eighty":-60.438055,"marketCap":2733760852},{"date":"2024-03-28","current":-56.207672,"twenty":-71.967566,"median":-64.762028,"eighty":-59.842879,"marketCap":2732086332},{"date":"2024-04-05","current":-51.752186,"twenty":-71.648838,"median":-63.50175,"eighty":-58.14191,"marketCap":2515518513},{"date":"2024-04-12","current":-54.631116,"twenty":-71.284577,"median":-62.382039,"eighty":-56.136384,"marketCap":2655454642},{"date":"2024-04-19","current":-48.420853,"twenty":-71.001624,"median":-61.712969,"eighty":-54.576279,"marketCap":2353592420},{"date":"2024-04-26","current":-49.627262,"twenty":-70.73168,"median":-60.54213,"eighty":-53.208102,"marketCap":2412232322},{"date":"2024-05-03","current":-54.151294,"twenty":-70.286112,"median":-60.183337,"eighty":-53.600185,"marketCap":2632131954},{"date":"2024-05-10","current":-35.176138,"twenty":-69.778748,"median":-59.371617,"eighty":-52.278619,"marketCap":2000537303},{"date":"2024-05-17","current":-36.289307,"twenty":-68.393255,"median":-58.232975,"eighty":-49.860318,"marketCap":2063845445},{"date":"2024-05-24","current":-35.140985,"twenty":-67.52163,"median":-57.330453,"eighty":-49.032283,"marketCap":1998538098},{"date":"2024-05-31","current":-40.179539,"twenty":-67.228921,"median":-56.207672,"eighty":-47.173317,"marketCap":2285090743},{"date":"2024-06-07","current":-40.894311,"twenty":-66.477632,"median":-55.878652,"eighty":-42.192617,"marketCap":2325741235},{"date":"2024-06-14","current":-40.788853,"twenty":-65.885708,"median":-55.522213,"eighty":-41.278647,"marketCap":2319743621},{"date":"2024-06-21","current":-37.625109,"twenty":-65.85969,"median":-54.631116,"eighty":-40.788853,"marketCap":2139815216},{"date":"2024-06-28","current":-35.445642,"twenty":-65.443392,"median":-54.494024,"eighty":-40.683395,"marketCap":2015864537},{"date":"2024-07-05","current":-36.125261,"twenty":-64.796178,"median":-54.151294,"eighty":-39.560851,"marketCap":2054515824},{"date":"2024-07-12","current":-40.378738,"twenty":-64.675841,"median":-53.136814,"eighty":-38.206301,"marketCap":2296419569},{"date":"2024-07-15","current":-41.491907,"twenty":-64.64657,"median":-52.780375,"eighty":-38.236766,"marketCap":2359727711},{"date":"2024-08-02","current":-39.652248,"twenty":-64.6173,"median":-52.752957,"eighty":-38.267232,"marketCap":2255102676},{"date":"2024-08-09","current":-38.949194,"twenty":-63.924553,"median":-51.752186,"eighty":-38.000071,"marketCap":2215118586},{"date":"2024-08-16","current":-40.572681,"twenty":-63.472479,"median":-49.956283,"eighty":-38.105529,"marketCap":2307449488},{"date":"2024-08-23","current":-42.377221,"twenty":-62.965116,"median":-49.723226,"eighty":-38.189896,"marketCap":2410077328},{"date":"2024-08-30","current":-43.2618,"twenty":-62.33047,"median":-48.934948,"eighty":-38.276606,"marketCap":2460385093},{"date":"2024-09-06","current":-44.299706,"twenty":-62.063778,"median":-48.270052,"eighty":-38.375033,"marketCap":2519412871},{"date":"2024-09-13","current":-41.079839,"twenty":-61.869081,"median":-45.980618,"eighty":-38.588613,"marketCap":2336292606},{"date":"2024-09-20","current":-46.127835,"twenty":-61.368222,"median":-44.806865,"eighty":-38.861791,"marketCap":2623382252},{"date":"2024-09-27","current":-43.379744,"twenty":-60.747027,"median":-44.736098,"eighty":-39.046612,"marketCap":2467092795},{"date":"2024-10-04","current":-42.412604,"twenty":-60.551887,"median":-44.517902,"eighty":-39.324835,"marketCap":2412089639},{"date":"2024-10-11","current":-40.667036,"twenty":-60.382766,"median":-44.458898,"eighty":-39.52313,"marketCap":2312815649},{"date":"2024-10-18","current":-43.356155,"twenty":-60.203473,"median":-44.063818,"eighty":-39.574912,"marketCap":2465751255},{"date":"2024-10-25","current":-42.990529,"twenty":-60.177247,"median":-43.698192,"eighty":-39.657154,"marketCap":2444957379},{"date":"2024-10-31","current":-42.837202,"twenty":-60.01213,"median":-43.662809,"eighty":-39.673778,"marketCap":2436237366},{"date":"2024-11-08","current":-46.068863,"twenty":-59.381569,"median":-43.651015,"eighty":-39.804577,"marketCap":2620028401},{"date":"2024-11-15","current":-32.980568,"twenty":-59.208121,"median":-43.63922,"eighty":-39.654701,"marketCap":2400853462},{"date":"2024-11-22","current":-30.044833,"twenty":-58.542987,"median":-43.538968,"eighty":-38.997903,"marketCap":2187143689},{"date":"2024-11-29","current":-32.283796,"twenty":-58.232975,"median":-43.444613,"eighty":-38.328163,"marketCap":2350131206},{"date":"2024-12-06","current":-31.17825,"twenty":-58.005312,"median":-43.379744,"eighty":-38.000071,"marketCap":2269651893},{"date":"2024-12-13","current":-26.821099,"twenty":-57.745125,"median":-43.279491,"eighty":-37.543086,"marketCap":1952468717},{"date":"2024-12-20","current":-26.031423,"twenty":-56.915781,"median":-43.120267,"eighty":-36.394765,"marketCap":1894983493},{"date":"2024-12-27","current":-27.044066,"twenty":-56.349294,"median":-43.061296,"eighty":-36.125261,"marketCap":1968699839},{"date":"2025-01-03","current":-26.914002,"twenty":-56.207672,"median":-43.037707,"eighty":-35.33784,"marketCap":1959231684},{"date":"2025-01-10","current":-28.298257,"twenty":-56.136384,"median":-42.978735,"eighty":-34.953504,"marketCap":2059999900},{"date":"2025-01-17","current":-27.034776,"twenty":-55.969133,"median":-42.872585,"eighty":-33.374909,"marketCap":1968023542},{"date":"2025-01-24","current":-32.158189,"twenty":-55.840266,"median":-42.689773,"eighty":-32.852839,"marketCap":2340987506},{"date":"2025-01-31","current":-31.530712,"twenty":-55.653821,"median":-42.565931,"eighty":-32.283796,"marketCap":2295309701},{"date":"2025-02-07","current":-31.405216,"twenty":-55.437216,"median":-42.394913,"eighty":-32.036945,"marketCap":2286174140},{"date":"2025-02-14","current":-29.805151,"twenty":-55.004006,"median":-42.206678,"eighty":-31.677123,"marketCap":2169695737},{"date":"2025-02-21","current":-29.512328,"twenty":-54.631116,"median":-41.999801,"eighty":-31.530712,"marketCap":2148379428},{"date":"2025-02-28","current":-25.768383,"twenty":-54.494024,"median":-41.775708,"eighty":-31.373843,"marketCap":1875835192},{"date":"2025-03-07","current":-28.226,"twenty":-54.39406,"median":-41.609082,"eighty":-31.094637,"marketCap":2054739928},{"date":"2025-03-14","current":-27.138374,"twenty":-54.151294,"median":-41.292708,"eighty":-30.560445,"marketCap":1975565066},{"date":"2025-03-21","current":-29.020804,"twenty":-53.671473,"median":-41.068045,"eighty":-30.21301,"marketCap":2112598481},{"date":"2025-03-28","current":-28.173711,"twenty":-53.493253,"median":-40.922206,"eighty":-29.826066,"marketCap":2050933444},{"date":"2025-04-04","current":-16.223536,"twenty":-52.780375,"median":-40.788853,"eighty":-29.478125,"marketCap":1428303862},{"date":"2025-04-11","current":-15.26259,"twenty":-52.725539,"median":-40.592885,"eighty":-29.073094,"marketCap":1343703153},{"date":"2025-04-17","current":-17.504797,"twenty":-52.648767,"median":-40.36956,"eighty":-28.807616,"marketCap":1541104808},{"date":"2025-04-25","current":-18.630229,"twenty":-51.927664,"median":-39.710836,"eighty":-28.715432,"marketCap":1640186719},{"date":"2025-05-02","current":-24.014988,"twenty":-51.631545,"median":-39.587801,"eighty":-28.276198,"marketCap":2114255557},{"date":"2025-05-09","current":-20.891121,"twenty":-50.318205,"median":-39.192738,"eighty":-28.046644,"marketCap":1839233409},{"date":"2025-05-16","current":-18.305859,"twenty":-49.931606,"median":-38.624431,"eighty":-27.822323,"marketCap":1932311557},{"date":"2025-05-23","current":-18.60193,"twenty":-49.805481,"median":-38.19927,"eighty":-27.481395,"marketCap":1963563934},{"date":"2025-05-30","current":-18.941329,"twenty":-49.745161,"median":-38.000071,"eighty":-27.137812,"marketCap":1999389828},{"date":"2025-06-06","current":-19.230179,"twenty":-49.665648,"median":-37.795014,"eighty":-26.986466,"marketCap":2029879952},{"date":"2025-06-13","current":-19.136302,"twenty":-49.503879,"median":-37.543086,"eighty":-26.644583,"marketCap":2019970662},{"date":"2025-06-20","current":-18.977435,"twenty":-49.032283,"median":-37.168124,"eighty":-26.449487,"marketCap":2003201094}],"updateTime":1750600899746}}}